Literature DB >> 15825186

Neuromuscular manifestations of critical illness.

Charles F Bolton1.   

Abstract

Critical illness, more precisely defined as the systemic inflammatory response syndrome (SIRS), occurs in 20%-50% of patients who have been on mechanical ventilation for more than 1 week in an intensive care unit. Critical illness polyneuropathy (CIP) and myopathy (CIM), singly or in combination, occur commonly in these patients and present as limb weakness and difficulty in weaning from the ventilator. Critical illness myopathy can be subdivided into thick-filament (myosin) loss, cachectic myopathy, acute rhabdomyolysis, and acute necrotizing myopathy of intensive care. SIRS is the predominant underlying factor in CIP and is likely a factor in CIM even though the effects of neuromuscular blocking agents and steroids predominate in CIM. Identification and characterization of the polyneuropathy and myopathy depend upon neurological examination, electrophysiological studies, measurement of serum creatine kinase, and, if features suggest a myopathy, muscle biopsy. The information is valuable in deciding treatment and prognosis.

Entities:  

Mesh:

Year:  2005        PMID: 15825186     DOI: 10.1002/mus.20304

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  87 in total

Review 1.  Intensive care unit-acquired weakness: implications for physical therapist management.

Authors:  Amy Nordon-Craft; Marc Moss; Dianna Quan; Margaret Schenkman
Journal:  Phys Ther       Date:  2012-01-26

Review 2.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

Review 3.  Diagnosis of acute neuropathies.

Authors:  Clarissa Crone; Christian Krarup
Journal:  J Neurol       Date:  2007-09-21       Impact factor: 4.849

4.  Critical illness polyneuropathy following childhood appendicitis.

Authors:  D Mullassery; A Curran; P D Losty
Journal:  Pediatr Surg Int       Date:  2008-07-30       Impact factor: 1.827

5.  The role of endotoxin in critical illness myopathy and polyneuropathy.

Authors:  Jörg Ahrens; Martin Leuwer; Nilufar Foadi; Gertrud Haeseler
Journal:  J Neurol       Date:  2009-03-22       Impact factor: 4.849

6.  Review of Critical Illness Myopathy and Neuropathy.

Authors:  Starane Shepherd; Ayush Batra; David P Lerner
Journal:  Neurohospitalist       Date:  2016-08-23

Review 7.  Critical illness polyneuropathy and myopathy in the intensive care unit.

Authors:  Wolfgang Zink; Rainer Kollmar; Stefan Schwab
Journal:  Nat Rev Neurol       Date:  2009-07       Impact factor: 42.937

8.  Get out of bed: immobility in the neurologic ICU.

Authors:  Claire J Creutzfeldt; Catherine L Hough
Journal:  Crit Care Med       Date:  2015-04       Impact factor: 7.598

9.  Occurrence of neuropathies in patients with severe heart failure before and after heart transplantation.

Authors:  Sergio Bagnato; Chiara Minà; Antonino Sant'Angelo; Cristina Boccagni; Caterina Prestandrea; Alessandra Caronia; Francesco Clemenza; Giuseppe Galardi
Journal:  Neurol Sci       Date:  2015-11-14       Impact factor: 3.307

10.  Role of endotoxin in the pathogenesis of critical illness polyneuropathy.

Authors:  B Mohammadi; I Schedel; K Graf; A Teiwes; H Hecker; B Haameijer; D Scheinichen; S Piepenbrock; R Dengler; J Bufler
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.